Patents by Inventor Jianfeng BAI

Jianfeng BAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240111661
    Abstract: An embodiment of this application provides a method and apparatus for testing control software, and a computer-readable storage medium to reduce the time consumed in the simulation-based debugging and enhance efficiency. The method may include obtaining test information of a plurality of fault signals; and injecting, based on the test information of the plurality of fault signals, the plurality of fault signals into a simulation environment in sequence to obtain test results of the plurality of fault signals handled by the control software, where the simulation environment may be a simulation environment of a control object of the control software.
    Type: Application
    Filed: August 14, 2023
    Publication date: April 4, 2024
    Applicant: CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED
    Inventors: Bin LAN, Xuming WANG, Deqiang SHI, Chunguang YE, Runqi WU, Jianfeng GUO, Chang LIU, Dongfei ZHANG, Jianping BAI, Lang YANG, Xuan HE
  • Patent number: 11767232
    Abstract: The present invention provides a process for continuous treatment of high-concentration organic wastewater and a device for continuous treatment of high-concentration organic wastewater. The process of the present application is that: high-concentration organic wastewater is continuously separated through the synergistic interaction of a multilayer evaporator and a heat pump, and the generated wastewater steam containing light components is continuously subjected to desulfurization and catalytic combustion after being mixed with air in a gaseous form, the treated wastewater can meet discharge standards, and heavy components of the generated wastewater can be recycled.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: September 26, 2023
    Assignee: ZHEJIANG UNIVERSITY OF TECHNOLOGY
    Inventors: Yong Nie, Shangzhi Yu, Xiaojiang Liang, Qinglong Xie, Zhenyu Wu, Jianfeng Bai
  • Patent number: 11701349
    Abstract: The present invention provides a pharmaceutical composition comprising (R, E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy) phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidinyl-2-yl)-acrylamide or a pharmacologically acceptable salt thereof, which is obtained by mixing the quinoline derivative or a pharmacologically acceptable salt thereof, a wetting agent, a disintegrant, and at least one pharmaceutical excipient; granulating; dynamic drying; and optionally compressing into tablets or filling into capsules after mixing with a lubricant.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: July 18, 2023
    Assignee: JIANGSU HENGRUI MEDICINE CO., LTD.
    Inventors: Xinhua Zhang, Chenyang Wang, Daimei Zhang, Jianfeng Bai
  • Publication number: 20210331943
    Abstract: The present invention provides a process for continuous treatment of high-concentration organic wastewater and a device for continuous treatment of high-concentration organic wastewater. The process of the present application is that: high-concentration organic wastewater is continuously separated through the synergistic interaction of a multilayer evaporator and a heat pump, and the generated wastewater steam containing light components is continuously subjected to desulfurization and catalytic combustion after being mixed with air in a gaseous form, the treated wastewater can meet discharge standards, and heavy components of the generated wastewater can be recycled.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 28, 2021
    Applicant: ZHEJIANG UNIVERSITY OF TECHNOLOGY
    Inventors: Yong NIE, Shangzhi YU, Xiaojiang LIANG, Qinglong XIE, Zhenyu WU, Jianfeng BAI
  • Publication number: 20210186952
    Abstract: The present invention provides a pharmaceutical composition comprising quinoline derivative. Specifically, the present invention provides a process for preparing a pharmaceutical composition comprising (R, E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy) phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidinyl-2-yl)-acrylamide or a pharmacologically acceptable salt thereof. The process for preparing is suitable for large-scale industrial production, and the obtained sample has the characteristics such as rapid and uniform dissolution.
    Type: Application
    Filed: October 23, 2018
    Publication date: June 24, 2021
    Applicant: JIANGSU HENGRUI MEDICINE CO., LTD.
    Inventors: Xinhua ZHANG, Chenyang WANG, Daimei ZHANG, Jianfeng BAI